EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   1.6.5.5 | Cataract |
1370456 |
Identification and characterization of the enzymatic activity of zeta-crystallin from guinea pig lens. A novel NADPH:quinone oxidoreductase. |
causal interaction
unassigned |
3
0 |
| 1.6.5.5 | Cataract |
1390943 |
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene. |
unassigned |
0 |
| 1.6.5.5 | Lens Diseases |
1390943 |
A guinea-pig hereditary cataract contains a splice-site deletion in a crystallin gene. |
unassigned |
0 |
| 1.6.5.5 | Carcinoma, Hepatocellular |
1549602 |
Rapid detection of inducers of enzymes that protect against carcinogens. |
ongoing research
unassigned |
3
0 |
| 1.6.5.5 | Cataract |
1623948 |
Mutant zeta-crystallin from guinea-pig hereditary cataracts has altered structural and enzymatic properties. |
unassigned |
0 |
| 1.6.5.5 | Cataract |
1695576 |
The transcripts of zeta-crystallin, a lens protein related to the alcohol dehydrogenase family, are altered in a guinea-pig hereditary cataract. |
unassigned |
0 |
| 1.6.5.5 | Neoplasms |
1739405 |
Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells. |
ongoing research
unassigned |
2
0 |
| 1.6.5.5 | Carcinoma |
1901207 |
The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide) |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
3
1
0 |
| 1.6.5.5 | Carcinogenesis |
2107967 |
Long term effects of benzo(a)pyrene on the activity of NAD(P)H:quinone reductase in the forestomach and glandular stomach of ICR/Ha mice. |
ongoing research
unassigned |
2
0 |
| 1.6.5.5 | Cataract |
2318275 |
Association of hereditary cataracts in strain 13/N guinea-pigs with mutation of the gene for zeta-crystallin. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
1
0 |
